Related Experiment Video
Updated: Jan 8, 2026
06:57
In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.6K
Therapy of cutaneous leishmaniasis
1Infectious Diseases Section, VA Connecticut Healthcare System, West Haven, CT 06516, USA. Samuel.lee@yale.edu
Summary
Treatment for cutaneous leishmaniasis is recommended for significant or progressing lesions. This review examines various therapeutic options for this skin condition.
Area of Science:
- Dermatology
- Infectious Diseases
- Parasitology
Background:
- Cutaneous leishmaniasis presents with varied lesion severity and progression.
- Therapeutic intervention is typically reserved for cosmetically significant, disfiguring, or progressive lesions.
- Numerous treatment modalities exist for managing cutaneous leishmaniasis.
Purpose of the Study:
- To review and synthesize the evidence supporting different therapeutic options for cutaneous leishmaniasis.
- To provide a comprehensive overview of available treatments for clinicians and researchers.
Main Methods:
- Systematic review of published literature on cutaneous leishmaniasis treatments.
- Analysis of evidence supporting various therapeutic modalities.
Main Results:
- The review covers a range of treatment options employed for cutaneous leishmaniasis.
- Evidence supporting each modality is summarized.
Conclusions:
- A variety of treatments are available for cutaneous leishmaniasis.
- Treatment decisions depend on lesion characteristics and progression.
